Actionnariat et activité des initiés pour Alterity Therapeutics Limited (ATHE): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $3.85 |
| Capitalisation | $65M |
| Bourse | NASDAQ |
| Pays | AU |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-08-31 | Marks Peter Ashley | P-Purchase | 47,620 | $24K |
| 2026-08-31 | Marks Peter Ashley | P-Purchase | 47,620 | $24K |
| 2026-08-31 | Stamler David Allen | P-Purchase | 47,620 | $24K |
| 2026-06-15 | Babarczy Julian Michael | A-Award | 2,000,000 | $2.0M |
| 2026-06-15 | Gozlan Lawrence Bernard | A-Award | 1,000,000 | $1.0M |
| 2026-04-17 | Cunningham Ann Michelle | |||
| 2026-04-15 | Stamler David Allen | |||
| 2026-04-15 | Stamler David Allen | |||
| 2026-04-15 | Stamler David Allen | 1,515,152 | $42K | |
| 2026-04-15 | Stamler David Allen | 2,380,952 | $24K |
Bilan (10 ans)
| Année | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $21.9M | $15.2M | $14.4M | $9.2M | $28.1M | $34.8M | $15.8M | $12.6M | $33.2M | $37.3M |
| Placements à Court Terme | $43988 | $9514 | 0 | 0 | 0 | 0 | 0 | 0 | $7.5M | 0 |
| Créances | $3.0M | $3.2M | $4.8M | $61321 | $4.1M | $4.7M | $8.6M | $4.0M | $3.9M | $7.7M |
| Stocks | $241625 | $256821 | $621737 | $567884 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $25.3M | $18.7M | $19.9M | $13.2M | $33.5M | $41.1M | $27.0M | $19.0M | $45.9M | $45.8M |
| Immobilisations Corporelles | $30815 | $71422 | $48748 | $71369 | $96808 | $218522 | $268863 | $186883 | $155174 | $190570 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Totaux | $25.3M | $18.7M | $19.9M | $13.3M | $33.6M | $41.4M | $27.3M | $19.2M | $46.0M | $46.0M |
| Dettes Fournisseurs | $65049 | $1.3M | $1.7M | $954033 | $1.4M | $2.6M | $1.7M | $581137 | $538276 | $1.1M |
| Dette à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $55177 |
| Passifs Courants | $1.6M | $2.6M | $3.3M | $2.7M | $3.1M | $5.8M | $4.4M | $5.4M | $3.5M | $3.2M |
| Dette à Long Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Totaux | $1.6M | $2.6M | $3.4M | $2.8M | $3.1M | $5.9M | $4.5M | $5.4M | $3.6M | $3.3M |
| Réserves | -$122.6M | -$129.6M | -$141.2M | -$151.0M | -$169.7M | -$181.9M | -$195.1M | -$214.2M | -$225.9M | -$245.6M |
| Capitaux Propres | $23.7M | $16.1M | $16.6M | $10.5M | $30.5M | $35.5M | $22.8M | $13.8M | $42.4M | $42.7M |
| Dette Totale | 0 | 0 | 0 | $33747 | $65649 | $117489 | $210384 | $159045 | $155457 | $193475 |
| Dette Nette | -$21.9M | -$15.2M | -$14.4M | -$9.2M | -$28.0M | -$34.7M | -$15.6M | -$12.5M | -$40.5M | -$37.1M |
| Fonds de Roulement | $23.7M | $16.0M | $16.5M | $10.5M | $30.4M | $35.3M | $22.7M | $13.7M | $42.3M | $42.7M |
Santé financière
| Dette / Capitaux propres | 0.00 |
| Ratio de liquidité | 14.52 |
Rentabilité
| Rentabilité des capitaux propres | -53.57% |
| Rentabilité du capital investi | -56.35% |
| Rentabilité des actifs | -49.74% |
| Marge brute | 0.00% |
| Marge opérationnelle | 0.00% |
| Marge nette | 0.00% |
Entreprises liées: ANVS · BTAI · DYAI · EVAX · GBIO · IGC · LIMN
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de ATHE: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions